Medicus Pharma Ltd. vs Jyong Biotech Ltd. — Valuation Comparison 2026
Access all valuation models for MDCX vs MENS — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.
Access Full Analysis — From $27/mo →MDCX scores higher with a 3.2/10 quality rating vs MENS's 2.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.
Comparing Medicus Pharma Ltd. (MDCX) and Jyong Biotech Ltd. (MENS) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.
MDCX currently trades at $0.38 with a QOC of 3.2/10, while MENS trades at $2.20 with a QOC of 2.3/10.
Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).